Clinical Dominant Disease of Traditional Chinese Medicine： Rheumatoid Arthritis
10.13422/j.cnki.syfjx.20251392
- VernacularTitle:中医药临床优势病种探讨——类风湿关节炎
- Author:
Jinping WANG
1
;
Qingwen TAO
1
;
Mei MO
2
;
Zihan WANG
1
;
Nan ZHANG
1
;
Yuan XU
1
;
Xiaoxiao ZHANG
3
Author Information
1. China-Japan Friendship Hospital ，National Integrated Traditional Chinese and Western Medicine Medical Center，Beijing 100029，China
2. National Key Laboratory of Chinese Medicine Modernization，Tianjin 300410，China
3. China Association of Chinese Medicine，Beijing 100029，China
- Publication Type:Journal Article
- Keywords:
rheumatoid arthritis;
clinical dominant disease;
traditional Chinese medicine;
integrated traditional Chinese and western medicine;
expert recommendation
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2025;31(17):202-210
- CountryChina
- Language:Chinese
-
Abstract:
Rheumatoid arthritis （RA） is an autoimmune disease characterized primarily by erosive arthritis， with a high prevalence and disability rate. Although significant progress has been made in the treatment of RA in recent years， challenges such as suboptimal efficacy， drug resistance， severe side effects， and high costs of long-term treatment remain， especially for patients in the early stages of RA， as well as those with RA complications， comorbidities， and severe conditions. Hosted by the China-Japan Friendship Hospital and organized by the Youth Committee of the China Association of Chinese Medicine， the 27th session of the Clinical Dominant Disease Series （Rheumatoid Arthritis） Youth Salon invited nearly 20 experts and scholars from traditional Chinese medicine （TCM）， western medicine， and interdisciplinary fields to actively discuss the clinical needs of modern medicine and the advantageous stages and aspects of TCM in RA. Experts at the salon agreed that TCM has unique advantages in the treatment of RA， especially during the early stage， periods of low to moderate disease activity， remission phase， and in addressing complications and comorbidities. TCM can achieve both prevention and treatment by regulating the immune system and restoring immune homeostasis. The integrated approach of traditional Chinese and western medicine demonstrates significant advantages in active RA， refractory cases， and stages with severe complications， by rapidly controlling disease progression， alleviating symptoms， enhancing the quality of life， and facilitating recovery. Given the frequent occurrence of multiple comorbidities in RA， TCM shows potential in regulating immunity， alleviating symptoms， and improving physical constitution， which provides new insights into the comprehensive treatment of RA with comorbidities. However， high-quality clinical studies on integrated traditional Chinese and western medicine in RA are still lacking. It is necessary to establish large-scale clinical cohorts and biological databases to provide a scientific basis for the development of precision-targeted therapies and clinical treatment protocols. In the future， individualized treatment strategies integrating traditional Chinese and western medicine are expected to become an important direction for improving the quality of life in RA patients.
